Trial intelligence / Profile preview

DF289 + DF277 in Acute Otitis Externa

NCT03196973Phase 3Completed

Sponsor
Laboratorios Salvat
Start
Jul 2017
Primary completion
Aug 2018
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of ciprofloxacin, fluocinolone in acute otitis externa (AOE), sponsored by Laboratorios Salvat. Started Jul 2017; status: completed.

02

Drugs

ciprofloxacinfluocinolone
03

Conditions

acute otitis externa (AOE)

Beyond the preview

Go deeper on NCT03196973.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03196973.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call